Cancer Chemotherapy And Pharmacology

雜志介紹

Cancer Chemotherapy And Pharmacology雜志介紹

《Cancer Chemotherapy And Pharmacology》是一本以English為主的未開放獲取國際優秀期刊，中文名稱癌癥化療和藥理學，本刊主要出版、報道醫學-PHARMACOLOGY & PHARMACY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為2.7，最新CiteScore 指數為6.1。

本刊近期中國學者發表的論文主要有：

• SMAGP regulates doxorubicin sensitivity in triple-negative breast cancer cells via modulating mitochondrial respiration

  Author: Xiao, Huawei; Yang, Xifeng; Huang, Shaoyan

• Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia

  Author: Li, Miao; Kong, Xiao-Yan; Wang, Shu-Mei

• Population pharmacokinetics of ruxolitinib in children with hemophagocytic lymphohistiocytosis: focus on the drug-drug interactions

  Author: Li, Zhuo; Zhang, Qing; He, Huan; Sun, Ning; Zhang, Rui; Yang, Chang-Qing; Zhao, Li-Bo

• Value of whole-body dynamic F-18-FMISO PET/CT Patlak multi-parameter imaging for evaluating the early radiosensitizing effect of oleanolic acid on C6 rat gliomas

  Author: Cai, Ke; Zhang, Qingqing; Wang, Hui; Yu, Wenjing; Xue, Yangyang; Xu, Huiqin

英文介紹

Cancer Chemotherapy And Pharmacology雜志英文介紹

Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials. It is essential reading for pharmacologists and oncologists giving results recorded in the following areas: clinical toxicology, pharmacokinetics, pharmacodynamics, drug interactions, and indications for chemotherapy in cancer treatment strategy.